Loading live market data…

Heron Therapeutics, Inc.

NASDAQ:HRTX

$0.4206 USD

-$0.01 (-2.16%)

Volume
1.59M
Average Volume
3.39M
Market Capitalization
$66.43M
P/E Ratio
-2.37
Dividend Yield
0.00%
Price Target
$6.00
Year High
$2.09
Year Low
$0.38
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.53

HRTX Estimated and Actual Revenue by Quarter

HRTX Estimated and Actual EPS by Quarter

HRTX Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 1 -28.22M -27.34M -27.78M -28.74M -27.85M -28.29M
2026-09-30 1 -25.29M -24.5M -24.9M -25.76M -24.96M -25.36M
2026-06-30 1 -25.44M -24.64M -25.04M -25.91M -25.1M -25.5M
2026-03-31 2 -22.16M -21.41M -21.79M -22.58M -21.81M -22.2M
2025-12-31 2 -23.69M -23.63M -23.66M -24.13M -24.07M -24.1M
2025-09-30 3 -23.48M -22.84M -23.16M -23.92M -23.26M -23.59M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 1 -1.94M -1.86M -1.9M 47.24M 48.76M 48M
2026-09-30 1 -1.94M -1.86M -1.9M 42.35M 43.71M 43.03M
2026-06-30 1 -967.75K -928.71K -948.23K 42.58M 43.95M 43.27M
2026-03-31 2 -5.9M -2.95M -4.43M 37M 38.3M 37.66M
2025-12-31 2 -3.87M -3.71M -3.79M 40.83M 40.94M 40.89M
2025-09-30 3 -2.9M -2.79M -2.84M 39.47M 40.58M 40.03M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 1 46.07M 47.55M 46.81M 1 -0.01020587 -0.00979413 -0.01
2026-09-30 1 41.29M 42.62M 41.95M 1 -0.01020587 -0.00979413 -0.01
2026-06-30 1 41.52M 42.86M 42.19M 1 -0.00510293 -0.00489707 -0.005
2026-03-31 2 36.08M 37.35M 36.72M 1 -0.03111067 -0.01555533 -0.023333
2025-12-31 2 39.82M 39.92M 39.87M 1 -0.02041173 -0.01958827 -0.02
2025-09-30 3 38.48M 39.57M 39.03M 2 -0.0153088 -0.0146912 -0.015